A more traditional health/biotech fund, the SPDR S&P Pharmaceuticals ETF(XPH Quote) is invested in cash-rich "big-pharma" firms that some industry analysts say are gearing up to acquire companies, such as those that kept BBH above water during the year.
XPH's biggest holdings include Bristol-Myers Squibb(BMY Quote), Abbott Labs(ABT Quote), Johnson & Johnson(JNJ Quote) and Pfizer (PFE Quote). Finally, the nearby table also includes the top three funds in a popular area of ETF investing: currency and commodity funds. Even though the U.S. dollar regained lost ground vis-Ã -vis the euro and U.K. pound, investors who speculated on the strength of the Swiss franc and the Japanese yen by buying the currency ETFs in the table achieved profits in 2008.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
- Loading Comments...
- Loading Comments...
Recent Comments
Featured Photo Galleries
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,405.83 | 1,102.35 | 2,190.86 | 34.82 |
Oil *
71.98
|
|
UP
68.78
|
UP
6.41
|
UP
7.13
|
UP
0.59
|
10 Yr
3.48%
SPDR Gold
110.82
|
|
+0.67%
|
+0.58%
|
+0.33%
|
+1.72%
|
Data delayed 20 minutes |














